The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias. We have dedicated our funding to several key areas:

  • Translational research to develop new drugs and build preclinical evidence
  • IND-enabling studies and early-stage clinical trials for novel and repurposed drugs
  • Development and validation of plasma, CSF, neuroimaging and digital biomarkers
  • Epidemiological studies and comparative effectiveness research

Applications are reviewed throughout the year through our core programs. Check back regularly for additional joint funding opportunities with our partners in non-profits, government, and industry.

CORE FUNDING PROGRAMS

NOW ACCEPTING APPLICATIONS
Upcoming 2020 deadlines
Must be received by 5:00 pm ET on the deadline date.

Letter of Intent
January 17, 2020

Invited Full Proposal
February 7, 2020

Letter of Intent
April 10, 2020

Invited Full Proposal
May 8, 2020

Letter of Intent
July 10, 2020

Invited Full Proposal
August 7, 2020

Letter of Intent
October 9, 2020

Invited Full Proposal
November 6, 2020

 
 

Drug Development RFP
Program to Accelerate Clinical Trials (PACT) RFP
Neuroimaging and CSF Biomarker Development RFP
Prevention Beyond the Pipeline RFP

ADDF/NIH Funding and SBIR/STTR Bridge Funding Opportunities

 
 

DIAGNOSTICS ACCELERATOR PROGRAMS

ACCEPTING APPLICATIONS ON A ROLLING BASIS

Learn more about the Diagnostics Accelerator here
Peripheral Biomarkers RFP
Digital Biomarkers RFP

 
 

OTHER FUNDING OPPORTUNITIES WITH OUR PARTNERS

ADDF-Harrington Scholar Program RFP (opens in February 2020)
Accelerating Drug Discovery for FTD RFP (opens in June 2020)
The Treat FTD RFP for Clinical Trials (deadline past)

 
 

CONFERENCE FUNDING

Supports scientific conferences that are relevant to our mission with grants up to $10,000. For more information, email grants@alzdiscovery.org with a brief summary of your conference.

 
 

ADDF FUNDING PORTAL

LOG IN OR CREATE ACCOUNT

 
 

 

Stay updated on upcoming deadlines and RFP announcements
Sign up to receive news by email.